baber/WOPTO huggingface dataset:
Patent CA-3125182-A1 (CA)
Title: Advanced gravity-moment-hydro power system
Inventor: EKANEM NSISUK OSMUND
IPC: F03B17/02
Filed: 2019-12-26
Abstract: A power generating system based solely on gravity includes a housing with water in a main chamber. A convertible piston interacts with the water to move to displace the water in a cycle. The displaced water is directed into and through power generating units, with the outputted water from one power generating unit continued towards and through a subsequent power generating unit as the water moves back towards the main chamber of the housing. The water is then able to interact again with the convertible piston to again be displaced through the power generation cycle. At least two separate power generating systems are integrated for uninterrupted power supply for 24hrs per day, 7 day per week and 365 days per year. This cycle continues (not in the concept of perpetual motion), as needed, to create energy that can be used on-demand or otherwise stored for future use.
Patent CA-3125264-A1 (CA)
Inventor: SAAD ROGINA
IPC: C09D133/04
Filed: 2019-05-21
Abstract: L'invention concerne une composition aqueuse de latex comprenant des particules de latex dispersées dans une solution aqueuse, les particules de latex étant polymérisées à partir d'au moins un monomère acrylique dans un environnement aqueux sensiblement exempt de solvant, et un composé de 2-oxazoline est incorporé aux particules de latex. Le composé 2-oxazoline présente la structure suivante : Le composé de 2-oxazoline est présent à un taux allant d'environ 1 % massique à environ 5 % massiques. La 2-oxazoline peut être greffée sur les particules de latex. La fraction R1 peut être exempte d'un radical organique acyclique ayant une fraction d'insaturation polymérisable par addition. La composition de latex aqueuse peut également comprendre un monomère acide.
Patent CA-3125409-A1 (CA)
Title: Control of selective catalytic reduction in heavy-duty motor vehicle engines
Inventor: WEBB CYNTHIA CHAFFIN
IPC: F02D43/00
Filed: 2021-07-21
Abstract: A heavy duty truck includes a diesel engine that generates an exhaust gas flow and an exhaust after-treatment system for treatment of the exhaust gas flow. The exhaust after-treatment system includes at least one temperature sensor at an underbody SCR system within the exhaust after-treatment system and a DEF injector upstream of a close-coupled SCR system within the exhaust after-treatment system. The DEF injector is operated to inject DEF into the exhaust gas flow at a rate that varies as a function of a temperature measured by the temperature sensor.
Patent CA-3126900-A1 (CA)
Inventor: ASHKENAZI EREZ
IPC: C12M1/34
Filed: 2020-01-14
Abstract: L'invention concerne un système et des procédés évolutifs pour la culture et la production de microorganismes photosynthétiques.
Patent CA-3127987-A1 (CA)
Inventor: PAMULAPARTHY BALAKRISHNA
IPC: G01R31/56
Filed: 2021-08-12
Abstract: Systems, methods, and computer-readable media are disclosed for enhanced electrical signature analysis (ESA) for fault detection in electrical machines. The enhanced ESA uses an algorithm that is able to adaptively learn the behavior of a particular electrical machine and automatically establish fault thresholds for the electrical machine without requiring manual inputs from an operator. The particular algorithm described herein to accomplish this may use machine learning that may be used to model the behavior of the electrical machine in real-time and based on any properties specific to the electrical machine.
Patent CA-3128942-A1 (CA)
Inventor: BILSBOROUGH JANINE
IPC: C12Q1/68
Filed: 2020-02-07
Abstract: Described herein are methods, systems, compositions, and kits useful for the diagnosis and/or treatment of a disease or condition in a subject. The present disclosure relates to methods and systems for identifying and stratifying patients suitable for treatment with a SKAP2 modulator, as described herein.
Patent CA-3129064-A1 (CA)
Inventor: RAJFER JACOB
IPC: A61K36/77
Filed: 2020-02-05
Abstract: A method for treatment of constipation and other ailments of the gastrointestinal system includes administering a pharmaceutically effective amount of a composition over a sufficient period of time that results in the production of nitric oxide in gastrointestinal cells and ultimately has beneficial results in treating constipation and other ailments of the gastrointestinal system. The composition comprises ginger or a ginger derivative, muira puama, and paullinia cupana that stimulates nitric oxide in gastrointestinal cells to increase NO and improve bowel functioning thereof.
Patent CA-3129586-A1 (CA)
Title: A system and a method for controlling a work machine
Inventor: TAKAOKA YUKIHISA
IPC: E02F9/20
Filed: 2020-04-07
Abstract: In the present invention, on the basis of current geographic data, a processor displays, on a display, site images that indicate at least a portion of a worksite. The processor acquires area data. The area data includes the location and size of a work area that is specified on the site image by an input device. The processor acquires work data showing the work direction in the work area. The processor determines the layout of a plurality of work lanes in the work area on the basis of the area data and the work data. The plurality of work lanes extends in the work direction. The processor sends a command for automatic operation to a work machine according to the layout of the work lanes.
Patent CA-3130247-A1 (CA)
Title: Fgfr inhibitor compound in solid form and preparation method therefor
Inventor: FU ZHIFEI
IPC: C07D487/04
Filed: 2020-02-14
Abstract: Disclosed are the solid form, crystalline form, crystal form A of a compound of formula (I), and a preparation method therefor, crystal form B and a preparation method therefor. Also disclosed are use of the solid form, crystalline form, crystal form A, and crystal form B in the preparation of drugs for the treatment of diseases related to FGFR.
Patent CA-3133046-A1 (CA)
Inventor: MICHELOT CLAUDE BERNARD
IPC: B65D83/24
Filed: 2020-03-24
Abstract: The invention relates to a safety lid for an aerosol container, comprising a dome surrounding at least part of a diffuser device and provided with a movable component (20), which can move between a first position for preventing the operation of the diffuser device, a second position for intermittently activating the diffuser device and a third position for emptying the container, said movable component (20') comprising means for permanently activating the diffuser device in the third position.
Patent CA-3133203-A1 (CA)
Inventor: ALESSIO ANDREA
IPC: A01G31/02
Filed: 2020-03-13
Abstract: A method for cultivating plant products without soil, comprising the following steps: preparing at least one cultivation shelf (7), which comprises one or more seeding and growth bars (9) made of plastic material, which are provided with seats (10) adapted to house seeds (SM) and have on the corresponding bottom walls (11) a through opening (12) structured for being traversed by, and remaining in direct contact with, the roots of the plant product during growth thereof, arranging seeds (SM) within the seats (10) in direct contact with the inner surface of said seats (10), without any interposition of one or more support/gripping layers of the roots of the plant products supplying the bars (9) with fertilizer- based substances.
Patent CA-3133290-A1 (CA)
Inventor: SMITH ISIAH DANIEL
IPC: B05C21/00
Filed: 2021-10-05
Abstract: A system including an adhesive dispensing device and a charger base. The adhesive dispensing device includes a first light emitting device, a handle, a power source, and a power supply interface. The charger base includes a second light emitting device, an interface formed for receiving the adhesive dispensing device, an external power output interface, and a power supply circuit. The external power output interface is configured to electrically couple to the power supply interface of the adhesive dispensing device. The first light emitting device is configured to illuminate in response to power being provided to the power supply interface from the power supply circuit. The second light emitting device is configured to illuminate in response to power being provided to the power supply circuit from the external power output interface.
Patent CA-3139492-A1 (CA)
Title: Modified antibody constant region
Inventor: IGAWA TOMOYUKI
IPC: C07K16/00
Filed: 2008-09-26
Abstract: The present inventors succeeded in improving the antibody constant region to have increased stability under acid conditions, reduced heterogeneity originated from disulfide bonds in the hinge region, reduced heterogeneity originated from the H chain C terminus, and increased stability at high concentrations as well as in discovering novel constant region sequences having reduced Fc.gamma. receptor-binding, while minimizing the generation of novel T-cell epitope peptides. As a result, the present inventors successfully discovered antibody constant regions with improved physicochemical properties (stability and homogeneity), immunogenicity, safety, and pharmacokinetics.
Patent CA-3139496-A1 (CA)
Inventor: OLIPHANT KEN
IPC: G01S15/88
Filed: 2021-11-18
Abstract: An aspect provides an ultrasound device for non-destructive evaluation of a butt-fusion joint or electro-fusion joint, the device comprising: an ultrasonic unit; a transducer operable remotely from the ultrasonic unit and including an ultrasound signal transmitter positionable to transmit the signal towards the joint, and an ultrasound signal receiver positionable to detect a reflection of the signal; a processor; memory including instructions executable by the processor and first data relating to a plurality of first sample joints of acceptable quality and second data relating to a plurality of second sample joints of unacceptable quality; and an output device. The instructions include a machine learning algorithm trained for analysis of the joint and to send assessment output to the output device indicative of whether the joint is of acceptable or unacceptable quality based on the signal reflection and the first and second data.
Patent CA-3139794-A1 (CA)
Title: Electrode-feed device
Inventor: TAKALI SABRI
IPC: H05B7/00
Filed: 2020-05-11
Abstract: The invention relates to an electrode-feed device feeding electrodes to a plasma torch installation, comprising an element (3) for securing an active electrode (6), able to move in translation along a longitudinal axis of the active electrode (6), characterized in that it further exhibits: - a magazine (2) comprising housings (28) each able to accept one electrode (7) out of a plurality of additional electrodes (7); - a movement system (4) for moving the housings (28) and configured to place one additional electrode out of the plurality of additional electrodes (7) in line with a current active electrode (6) along the longitudinal axis, - an assembly device configured to join a proximal end (61) of the current active electrode (6) end-to-end with a distal end (72) of the additional electrode (7) so that they together form a new active electrode.
Patent CA-3142984-A1 (CA)
Title: Rna formulations suitable for therapy
Inventor: HAAS HEINRICH
IPC: A61K39/145
Filed: 2020-07-01
Abstract: The present invention relates to compositions comprising RNA, preferably messenger RNA (mRNA), more preferably self-amplifying RNA (saRNA), and polymers, in particular cationic polymers, such as polyethylenimine (PEI), poly-L-Lysin (PEL), polyvinylamine (PVA) or polyallylamine (PAA), where individual RNA molecules are present in solution. In the formulations, the RNA is preferentially present in the form of monomers, dimers, timers or oligomers, but not as aggregates comprising a large number of RNA molecules per aggregate, in particular large polyplex nanoparticles. The formulations display improved transfection efficacy and they can be used for delivery of RNA to a subject, where they have an improved dose response relationship in comparison to formulations where large aggregates in the form of polyplex nanoparticles are present.
Patent CA-3143812-A1 (CA)
Title: Method of forming and using a hemostatic hydrocolloid
Inventor: NAJIBI SASAN
IPC: A61L15/24
Filed: 2020-07-20
Abstract: A method and system for forming a hemostatic hydrocolloid for dispensing into a wound site includes a polymer of oxidized derivatized esterified cellulose in solid form comprising a chain of monomers, wherein, for a first plurality of the monomers in the chain: R is - OCH<sub>2</sub>(COO)CH<sub>2</sub>CH<sub>3</sub>, R1 is - OCH<sub>2</sub>(COO)CH<sub>2</sub>CH<sub>3</sub>, and R2 is - CH<sub>2</sub>OCH<sub>2</sub>(COO)CH<sub>2</sub>CH<sub>3</sub>; and wherein, for a second plurality of monomers in the chain: R is - OCH<sub>2</sub>(COO)CH<sub>2</sub>CH<sub>3</sub>, R1 is - OCH<sub>2</sub>(COO)CH<sub>2</sub>CH<sub>3,</sub> and R2 is - (COO)CH<sub>2</sub>CH<sub>3</sub> and a liquid mixed with the polymer to form a hemostatic gel for dispensing into a wound site.
Patent CA-3144782-A1 (CA)
Title: Device and method for determining liquid contact and liquid volume in a liquid dispenser based on sound
Inventor: Wu pei-ming
IPC: G01F23/28
Filed: 2020-07-01
Abstract: Devices and methods for determining whether a contact of a liquid dispenser with a liquid based on sound and/or for determining a liquid volume in the liquid dispenser are provided. According to an embodiment, the liquid dispenser includes a sound generator and an acoustic sensor, and at least one of the sound generator or the acoustic sensor is disposed within the dispense chamber portion. According to an embodiment, the liquid dispenser includes a sound generator and an acoustic sensor, and further includes one or more side conduits, where at least one of the sound generator or the acoustic sensor is disposed within a cavity of a respective one of the one or more side conduits, wherein the cavity and a connector of each of the one or more side conduits are free from resonance within a frequency range of the sound sensed by the acoustic sensor.
Patent CA-3145870-A1 (CA)
Inventor: KARAGEOZIAN HAMPAR L
IPC: C07K7/06
Filed: 2020-07-24
Abstract: Uses of anti-integrin peptides for a) improving best corrected visual acuity of an eye of a subject suffering from non-exudative age related macular degeneration and/or b) improving color vision in an eye of a subject suffering from impaired color vision and/or for treatment of other disorders, and related methods.
Patent CA-3145901-A1 (CA)
Inventor: NAQVI SYED HUMZA
IPC: C11D3/14
Filed: 2020-04-07
Abstract: The application relates to stable, anhydrous dish soap formulation.
Patent CA-3147961-A1 (CA)
Title: Anti-fibrotic pyridinones
Inventor: BUCKMAN BRAD OWEN
IPC: C07D513/04
Filed: 2013-10-01
Abstract: Disclosed are pyridinone compounds, method for preparing these compounds, and methods for treating fibrotic disorders.
Patent CA-3153941-A1 (CA)
Inventor: POMEROY MARY
IPC: G01N33/86
Filed: 2019-10-17
Abstract: La présente invention concerne un procédé et un appareil pour déterminer l'activité de facteurs de coagulation dans le sang total capillaire dilué, le sang total citraté et le plasma citraté. L'invention comprend également la détection de la quantité d'hémoglobine dans un échantillon de sang total, de telle sorte qu'une correction du temps de coagulation peut être effectuée, ce qui rend les valeurs de temps de coagulation indépendantes de l'effet de l'hémoglobine et de l'hématocrite.
Patent CA-3155855-A1 (CA)
Inventor: HUIJUAN JIA
IPC: A61K9/00
Filed: 2020-12-07
Abstract: The present disclosure provides a sorafenib pharmaceutical composition with high bioavailability and use thereof, and specifically provides a low-dose sorafenib oral solid preparation, comprising: a) a sorafenib solid dispersion; b) a crystallization inhibitor; and c) additional pharmaceutically acceptable adjuvant. The aforementioned low-dose sorafenib oral solid preparation provided by the present disclosure has high bioavailability and reduces the dosage of sorafenib that the same therapeutic effect as that of Nexavar tablet can be achieved when a patient takes orally 35% to 70% of the administered dose of Nexavar tablet; it has higher stability, better safety, and less incidence of side effects; it has lower Cmax and AUCo-t variation, a higher dissolution, and a low crystal precipitation rate with the increase of pH in the gastrointestinal tract; it is easy to be taken by patients due to the small volume of the tablet; it has a fast disintegration speed and a good dissolution effect; and it is easy to realize industrialization.
Patent CA-3156630-A1 (CA)
Title: Compositions comprising quinone and/or quinol and methods of preparations and use thereof
Inventor: TAN BARRIE
IPC: B01J31/02
Filed: 2020-10-16
Abstract: The present embodiments are directed to compositions of quinones and/or quinols, such as, but not limited to, ubiquinone and/or ubiquinol, vitamin E quinone and/or vitamin E quinol, vitamin K quinone and/or vitamin K quinol, menaquinones and/or menaquinols, and pyrroloquinoline quinone and/or pyrroloquinoline quinol, and methods for preparations and use thereof. The present embodiments are also directed to compositions of reduced forms of curcuminoid and methods for preparations and use thereof.
Patent CA-3156820-A1 (CA)
Inventor: WALKER LUKE
IPC: A61P35/00
Filed: 2020-10-20
Abstract: Selon un aspect, la présente invention concerne une méthode de traitement ou d'atténuation des effets d'un cancer du sein HER2 positif chez un sujet par l'administration d'une association de tucatinib, de capécitabine et de trastuzumab. Selon certains modes de réalisation, les méthodes selon l'invention sont utiles pour traiter ou atténuer les effets d'une métastase cérébrale associée au cancer du sein HER2 positif chez un sujet par l'administration d'une association de tucatinib, de capécitabine et de trastuzumab.
Patent CA-3159489-A1 (CA)
Inventor: CUNNINGHAM OWEN A
IPC: F24H15/212
Filed: 2022-05-19
Abstract: Systems and methods are directed to water heater systems, including combi boilers and instantaneous water heaters, for initiating back up operations, e.g., for continuous flow and hot water delivery, in response to errors or interruptions to normal operations. Embodiments of the present invention can include, a plurality of heat exchangers, including a domestic hot water outlet, temperature sensors sensing water temperature at one or more locations within the water heater system, a control system. The control system can be configured to at least: monitor the water temperature measured by the first temperature sensor, identify an abnormality in monitoring the water temperature, initiate am alternative operation to sense water temperature via an alternate pathway and heat water to a set point value during the abnormality, and deliver water heated to the set point value during the abnormality.
Patent CA-3161917-A1 (CA)
Title: Methode et systeme pour la determination de l'emplacement et de l'orientation d'un objet en fond de trou
Inventor: MILNE CRAIG
IPC: E21B47/0224
Filed: 2015-05-15
Abstract: Des modes de réalisation de linvention concernent un dispositif de fond de trou qui est destiné à être situé conjointement avec un câble à fibres optiques à trouver, par exemple en étant fixés lun à lautre dans le même élément de serrage. Le dispositif comporte un accéléromètre ou un autre moyen de détermination dorientation approprié qui est apte à déterminer son orientation de position, par rapport à la gravité. Un vibreur ou un autre résonateur est prévu, lequel délivre en sortie les informations dorientation de position sous la forme dun signal acoustique codé et modulé approprié. Un capteur acoustique distribué à fibres optiques déployé dans le voisinage du dispositif de fond de trou détecte le signal acoustique, et le transmet en retour vers la surface, où il est démodulé et décodé pour obtenir les informations dorientation de position Étant donné que le dispositif est situé conjointement avec la fibre optique la position de la fibre peut ensuite être déduite. Tel quexpliqué ci-dessus, la détection de la position de fibre est importante pendant des opérations de perforation, de telle sorte que la fibre nest pas endommagée par inadvertance.
Patent CA-3162096-A1 (CA)
Inventor: KAGAN JONATHAN C
IPC: A61K39/39
Filed: 2020-11-18
Abstract: The present application is related to cancer immunotherapy, e.g. stimulation of T cell mediated anti-tumor therapy. Accordingly, described herein are methods of inducing or enhancing an adaptive immune response to a cancer in a subject and methods of treating cancer in a subject. In some embodiments, the methods hyperactivate dendritic cells (DCs), which induce T helper type I (TH1) and cytotoxic T lymphocyte (CTL) responses in the absence of TH2 immunity.
Patent CA-3165297-A1 (CA)
Title: Glufosinate formulations containing amines or ammonium salts
Inventor: MERTOGLU MURAT
IPC: A01N57/20
Filed: 2021-01-14
Abstract: The invention relates to a liquid herbicidal composition comprising a) glufosinate, or a salt thereof, an amine component; and a compound of formula (I) [R-(A)x-OSO3-]-M+ (I); wherein al variables have a meaning as defined herein. It also relates to a method for increasing the herbicidal activity of liquid herbicidal compositions comprising glufosinate or a salt thereof, and a compound of formula (I) comprising the step of contacting the liquid herbicidal composition with the amine component; and to a method for treating plant propagation material comprising the step of treating plant propagation material with the herbicidal composition.
Patent CA-3165724-A1 (CA)
Title: A method for coating a fibrous web, and a surface coated fibrous web
Inventor: BACKFOLK KAJ
IPC: B05C1/14
Filed: 2020-12-22
Abstract: A method is provided for coating a fibrous web, in particular a fibrous web comprising nanocellulose fibres. The method includes steps of applying a coating agent to a textured surface region of a textured substrate, applying a fibre furnish or a wet fibrous web onto the coated textured surface region of the textured substrate, optionally dewatering to provide a wet fibrous web, and drying said wet fibrous web such that at least a portion of said coating agent is transferred to said fibrous web. The method provides a coated fibrous web with improved barrier properties.
Patent CA-3166360-A1 (CA)
Title: Compositions pharmaceutiques stables de ropinirole
Inventor: LESKINEN MIKKO
IPC: A61K31/4045
Filed: 2021-02-02
Abstract: L'invention concerne des compositions aqueuses pharmaceutiques, par exemple des solutions, comprenant du ropinirole ou un sel pharmaceutiquement acceptable de celui-ci en tant que principe actif, la composition ayant une teneur réduite en fer. Les compositions présentent une stabilité chimique améliorée du principe actif. Les compositions peuvent être utilisées, par exemple, dans la préparation de compositions de gouttes oculaires pour induire des vomissements chez des animaux, en particulier des animaux de compagnie tels que des chiens et des chats, dans des situations où les vomissements sont souhaités.
Patent CA-3166599-A1 (CA)
Inventor: MANAVITEHRANI IMAN
IPC: A61F2/28
Filed: 2021-01-29
Abstract: Disclosed is a bioresorbable implant with enhanced bone ingrowth and tissue integration utilizing an inside-out resorption mechanism and a method to manufacture a bioresorbable implants for use in osteotomies and bone-soft tissue reconstruction surgeries. The bioresorbable implant includes a polymer A (e.g., an aliphatic polymer matrix) and/or poly(propylene fumarate)), a carbohydrate B (e.g., a bioresorbable natural carbohydrate filler) and a ceramic C. The implant may be a porous scaffold structures with suitable porosity, pore size, pore interconnectivity, and mechanical properties for enhanced osteoblast penetration and bone formation to fabricate tissue integrating bioresorbable implants. The implant may be shaped as wedges, bone void fillers, and soft tissue fixation implant like screws, rods and/or anchors. In some embodiments, the implant may be a putty.